Jeffrey Calabrese

Vice President of Finance, Aerie Pharmaceuticals.

Companies

Aerie PharmaceuticalsVice President of Finance Nov 8, 2021 to Nov 21, 2022¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Aerie Pharmaceuticals AERI0 shares²Nov 21, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Nov 21, 2022Returned to company 18,585 shares at $15.25 of Aerie Pharmaceuticals²
Nov 1, 2022Shares withheld for tax 179 shares at $15.22 of Aerie Pharmaceuticals³
Aug 14, 2022Shares withheld for tax 265 shares at $11.57 of Aerie Pharmaceuticals⁴
Jul 1, 2022Shares withheld for tax 266 shares at $8.36 of Aerie Pharmaceuticals⁵
Jul 1, 2022Granted 11,276 shares of Aerie Pharmaceuticals⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAerie Pharmaceuticals, Vice President of Finance
2
SEC EDGARAerie Pharmaceuticals shares after the filing of Nov 21, 2022
3
SEC EDGARForm 4 filed Nov 3, 2022
4
SEC EDGARForm 4 filed Aug 16, 2022
5
SEC EDGARForm 4 filed Jul 13, 2022
6
SEC EDGARForm 4 filed Jul 6, 2022